NovaXS Biotech Corp.

📍 Berkeley, United States🗓 Founded 2021👥 9 employees💰 Last funded Dec 2022
Biotechnology Research🌐 novaxs.co
Website LinkedIn
Led by a professional team in healthcare with a proven track record of over 40 million fundraising experience and 5 successful busines exits, NovaXS Biotech is on a mission to optimize patients’ medication self-administration experience and improve treatment outcomes. Our patent-pending technology, Telosis, is a patient-centric closed-loop drug delivery bio pharma solution that helps patients deliver medications subcutaneously or intramuscularly without a needle and manage their chronic condition and medication adherence on the patient engagement APP. The technology could also help pharmaceutical partners reduce their COG by 30%, increase revenue with improved patient compliance, and boost efficacy of medication with better absorption rate. Current partners and investors include Baxter, Edward-Elmhurst Health, Helixmith, etc.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in NovaXS Biotech Corp.?
NovaXS Biotech Corp. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did NovaXS Biotech Corp. last raise funding?
The most recent investment in NovaXS Biotech Corp. recorded on gritt.io was in December 2022.
When was NovaXS Biotech Corp. founded?
NovaXS Biotech Corp. was founded in 2021.
What industry is NovaXS Biotech Corp. in?
NovaXS Biotech Corp. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NovaXS Biotech Corp. based?
NovaXS Biotech Corp. is headquartered in Berkeley, United States.